Evolution of Cardiovascular Function and Quality of Life in Patients Included in the SCArabée Therapeutic Education Program

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

December 15, 2020

Study Completion Date

December 15, 2020

Conditions
Acute Coronary Syndrome
Interventions
DIAGNOSTIC_TEST

Cardiac stress test

In order to assess the evolution of their cardiorespiratory function, patients will benefit from two cardiac stress test combined with VO2 study, one at inclusion in the study, and the other one 6 months later.

Trial Locations (1)

38028

Groupe Hospitalier Mutualiste de Grenoble, Grenoble

All Listed Sponsors
collaborator

Fondation de l'Avenir

OTHER

lead

Groupe Hospitalier Mutualiste de Grenoble

OTHER

NCT03669211 - Evolution of Cardiovascular Function and Quality of Life in Patients Included in the SCArabée Therapeutic Education Program | Biotech Hunter | Biotech Hunter